Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies

被引:43
|
作者
Scosyrev, Emil [1 ]
Tobis, Scott [1 ]
Donsky, Heather [1 ]
Wu, Guan [1 ]
Joseph, Jean [1 ]
Rashid, Hani [1 ]
Messing, Edward [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA
关键词
biochemical recurrence; biochemical failure; prostate cancer; statins; RADICAL PROSTATECTOMY; CLINICAL PRESENTATION; PUBLICATION BIAS; ANTIGEN LEVELS; POPULATION; OUTCOMES; IMPACT; MEN;
D O I
10.1111/j.1464-410X.2012.11527.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
What's known on the subject? and What does the study add? Over the last few years, several observational studies examined the association of statin use with the risk of biochemical recurrence of prostate cancer after definitive local therapy. The objective of our present study was to summarise available evidence on this subject using the method of meta-analysis. Combined evidence from eight cohort studies did not definitively support the hypothesis that statins influence the risk of biochemical recurrence. However, there was considerable disagreement between individual studies in reported findings and conclusions. OBJECTIVE center dot To perform a systematic review and meta-analysis of clinical studies with statin use as the exposure variable and biochemical recurrence after definitive local therapy for prostate cancer as the outcome. METHODS center dot Relevant publications were identified through PubMed/Medline/Embase databases. center dot Pooled estimates of the hazard ratios (HRs) were computed using the inverse-variance weighting approach. center dot Heterogeneity was assessed using the Cochran's Q test. RESULTS center dot We identified a total of eight eligible studies, all based on the retrospective cohort design. Five of these were based on radical prostatectomy (RP) series and three on radiotherapy (RT) series. center dot There was evidence of heterogeneity in the entire set of eight studies (P= 0.002) as well as in the RP series (P= 0.05) and in the RT series (P= 0.01), when these were considered separately. center dot Based on the random effects inverse-variance weighting approach, pooled estimates of the HRs for the risk of biochemical recurrence in statin users v non-users were 0.91 (95% confidence interval [CI] 0.721.13) for the entire set of eight studies, 1.02 (95% CI 0.801.29) for the RP series and 0.71 (95% CI 0.441.16) for the RT series. CONCLUSION center dot The pooled estimates of the HRs were not significantly different from the null value in this meta-analysis; however, evidence of heterogeneity between the studies was present.
引用
收藏
页码:E71 / E77
页数:7
相关论文
共 50 条
  • [31] Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
    Qingling Hua
    Yanzhe Zhu
    Hu Liu
    Xiaobing Ye
    International Urology and Nephrology, 2016, 48 : 1437 - 1443
  • [32] Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
    Hua, Qingling
    Zhu, Yanzhe
    Liu, Hu
    Ye, Xiaobing
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (09) : 1437 - 1443
  • [33] Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer
    Roberts, Wilmer B.
    Han, Misop
    SURGICAL ONCOLOGY-OXFORD, 2009, 18 (03): : 268 - 274
  • [34] Management of Patients with Biochemical Recurrence After Local Therapy for Prostate Cancer
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    Eisenberger, Mario A.
    Carducci, Michael A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1205 - +
  • [35] IMPACT OF STATIN USE ON BIOCHEMICAL RECURRENCE IN PROSTATE CANCER PATIENTS TREATED WITH RADIATION THERAPY
    Lavigne, Danny
    Kaulanjan, Kevin
    Hoeh, Benedikt
    Saad, Fred
    Karakiewicz, Pierre I.
    Flammia, Rocco Simone
    Kluth, Luis Alex
    Mandel, Philipp
    Chun, Felix K. H.
    Taussky, Daniel
    RADIOTHERAPY AND ONCOLOGY, 2023, 186 : S67 - S68
  • [36] Preoperative Statin Therapy is not Associated with Biochemical Recurrence After Radical Prostatectomy: Our Experience and Meta-Analysis
    Mass, Alon Y.
    Agalliu, Ilir
    Laze, Juliana
    Lepor, Herbert
    JOURNAL OF UROLOGY, 2012, 188 (03): : 786 - 791
  • [37] Statin use and risk of pancreatic cancer: a meta-analysis
    Xiaobing Cui
    Yue Xie
    Min Chen
    Jun Li
    Xiaoming Liao
    Jian Shen
    Meng Shi
    Wenjing Li
    Haoxuan Zheng
    Bo Jiang
    Cancer Causes & Control, 2012, 23 : 1099 - 1111
  • [38] Statin use and endometrial cancer risk: a meta-analysis
    Yang, Jing
    Zhu, Qiaoling
    Liu, Qiao
    Wang, Yingxia
    Xie, Weimin
    Hu, Lili
    ONCOTARGET, 2017, 8 (37) : 62425 - 62434
  • [39] STATIN USE AND RISK OF BREAST CANCER: A META-ANALYSIS OF 24 OBSERVATIONAL STUDIES
    Undela, K.
    Srikanth, V
    VALUE IN HEALTH, 2012, 15 (07) : A413 - A413
  • [40] Statin use and risk of bladder cancer: a meta-analysis
    Zhang, Xiao-long
    Geng, Jiang
    Zhang, Xiao-peng
    Peng, Bo
    Che, Jian-ping
    Yan, Yang
    Wang, Guang-chun
    Xia, Sheng-qiang
    Wu, Yan
    Zheng, Jun-hua
    CANCER CAUSES & CONTROL, 2013, 24 (04) : 769 - 776